Guangdong Silver Age Sci & TechLtd Past Earnings Performance
Past criteria checks 3/6
Guangdong Silver Age Sci & TechLtd has been growing earnings at an average annual rate of 53.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 2.9% per year. Guangdong Silver Age Sci & TechLtd's return on equity is 2.9%, and it has net margins of 2.1%.
Key information
53.1%
Earnings growth rate
50.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 2.9% |
| Return on equity | 2.9% |
| Net Margin | 2.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Guangdong Silver Age Sci & TechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,874 | 39 | 141 | 97 |
| 30 Jun 24 | 1,779 | 37 | 142 | 87 |
| 31 Mar 24 | 1,683 | 28 | 152 | 84 |
| 31 Dec 23 | 1,665 | 27 | 155 | 80 |
| 30 Sep 23 | 1,655 | 30 | 161 | 81 |
| 30 Jun 23 | 1,657 | 23 | 163 | 78 |
| 31 Mar 23 | 1,753 | -2 | 190 | 78 |
| 01 Jan 23 | 1,846 | -5 | 196 | 82 |
| 30 Sep 22 | 2,107 | -4 | 237 | 96 |
| 30 Jun 22 | 2,212 | 8 | 222 | 101 |
| 31 Mar 22 | 2,283 | 44 | 201 | 105 |
| 01 Jan 22 | 2,253 | 73 | 182 | 106 |
| 30 Sep 21 | 2,062 | 95 | 133 | 97 |
| 30 Jun 21 | 1,978 | 126 | 138 | 94 |
| 31 Mar 21 | 1,843 | 140 | 118 | 92 |
| 31 Dec 20 | 1,641 | 101 | 110 | 87 |
| 30 Sep 20 | 1,511 | 47 | 125 | 83 |
| 30 Jun 20 | 1,409 | -25 | 126 | 82 |
| 31 Mar 20 | 1,330 | -193 | 144 | 82 |
| 31 Dec 19 | 1,511 | 10 | 154 | 86 |
| 30 Sep 19 | 1,610 | -798 | 428 | 91 |
| 30 Jun 19 | 1,820 | -784 | 447 | 98 |
| 31 Mar 19 | 2,047 | -663 | 452 | 104 |
| 31 Dec 18 | 2,263 | -805 | 467 | 110 |
| 30 Sep 18 | 2,577 | 96 | 215 | 110 |
| 30 Jun 18 | 2,634 | 158 | 151 | 162 |
| 31 Mar 18 | 2,749 | 225 | 197 | 134 |
| 31 Dec 17 | 2,563 | 219 | 211 | 108 |
| 30 Sep 17 | 2,200 | 158 | 201 | 79 |
| 30 Jun 17 | 1,959 | 155 | 262 | 0 |
| 31 Mar 17 | 1,622 | 154 | 222 | 0 |
| 31 Dec 16 | 1,441 | 153 | 203 | 0 |
| 30 Sep 16 | 1,325 | 154 | 199 | 0 |
| 30 Jun 16 | 1,216 | 115 | 186 | 0 |
| 31 Mar 16 | 1,192 | 74 | 176 | 0 |
| 31 Dec 15 | 1,149 | 40 | 168 | 0 |
| 30 Sep 15 | 1,138 | 38 | 149 | 0 |
| 30 Jun 15 | 1,143 | 37 | 144 | 0 |
| 31 Mar 15 | 1,107 | 27 | 132 | 0 |
| 31 Dec 14 | 1,107 | 24 | 124 | 0 |
| 30 Sep 14 | 1,071 | 20 | 115 | 0 |
| 30 Jun 14 | 1,026 | 15 | 104 | 0 |
| 31 Mar 14 | 999 | 13 | 107 | 0 |
| 31 Dec 13 | 968 | 12 | 106 | 0 |
Quality Earnings: 300221 has a high level of non-cash earnings.
Growing Profit Margin: 300221's current net profit margins (2.1%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300221 has become profitable over the past 5 years, growing earnings by 53.1% per year.
Accelerating Growth: 300221's earnings growth over the past year (32.5%) is below its 5-year average (53.1% per year).
Earnings vs Industry: 300221 earnings growth over the past year (32.5%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 300221's Return on Equity (2.9%) is considered low.